What you need to know
- 8.16dopamineA neurotransmitter in the brain involved in movement, reward and motivation. imbalance in Parkinson’s disease and serotoninA neurotransmitter in the brain involved in mood, sleep and appetite. imbalance in depression can contribute to ill health, and this knowledge is used in developing drugs.
Depression is not “just low serotonin”. The NHS page used here does not make that chemical claim. Do not give doses or tell anyone to start or stop a medicine. L-DOPA’s synapse detail is 8A 4.
By the end, you should be able to…
- Link Parkinson’s to loss of dopamine neurones in the substantia nigra.
- Describe serotonin’s possible contribution to depression without calling it the only cause.
- Explain the idea of a drug that raises transmission of a named transmitter.
Build your understanding
Dopamine and movement
dopamineA neurotransmitter in the brain involved in movement, reward and motivation. is a neurotransmitterA chemical released from a presynaptic neurone that diffuses across the synaptic cleft and binds to receptors on the next cell. in several brain pathways. One pathway runs from the substantia nigra and helps control movement. In Parkinson’s disease those cells are lost, so less dopamine is released at the synapses. The NHS describes the result as tremor, slow movement and stiff muscles. That matches the specification example of an imbalance contributing to ill health.
Drug development used that knowledge. L-DOPA can be converted to dopamine in the brain, as in 8A 4. Other drugs can mimic dopamine or slow its breakdown. None of them regrows the lost cells. Describing the idea is the specification point. Choosing a medicine for a person is not.
Serotonin is a contributor, not a whole explanation
serotoninA neurotransmitter in the brain involved in mood, sleep and appetite. is a neurotransmitter that affects mood, sleep and other functions. The specification says an imbalance can contribute to depression. Some medicines, such as selective reuptake inhibitors, leave more serotonin in the synaptic cleftThe narrow gap between two neurones at a synapse. so transmission increases. That is the same style of idea as raising dopamine: change the amount of transmitter at the synapse.
Do not write that depression is only a shortage of serotonin, or that a blood test of serotonin diagnoses it. The NHS describes depression as a low mood that lasts or keeps returning and that affects everyday life. That page does not blame a single chemical. Keep the specification sentence and the health-page sentence both true: serotonin signalling can contribute, and the illness is more than one molecule. MDMA also crowds serotonin into the cleft. It is not a treatment. It is harmful.
How a transmitter finding becomes a drug idea
If a pathway is underactive, a drug might increase synthesis of the transmitter, mimic it at the receptor, or block the enzymeA globular protein that acts as a biological catalyst, speeding up a specific reaction. or the reuptake pump that removes it. If a pathway is overactive, a drug might block the receptor. You should be able to suggest which of those fits a question’s description. You should not name a brand or a dose.
A new drug still has to be tested for benefit and harm. Knowing the synapse does not guarantee a safe medicine. Say that limit if you are asked to “evaluate”.
Make your reasoning visible
Cell loss, then transmitter
Parkinson’s: substantia nigra cells die, so dopamineA neurotransmitter in the brain involved in movement, reward and motivation. falls. The symptom list follows from that.
Contribute
Use the specification verb for serotoninA neurotransmitter in the brain involved in mood, sleep and appetite.. Do not upgrade it to “the only cause”.
Avoid this misconception
The claim: Depression is diagnosed by a low blood serotonin level, and dopamine tablets cure Parkinson’s disease.
The correction: Depression is a clinical illness, and serotonin is only one contributing transmitter. Dopamine itself does not readily enter the brain. L-DOPA can raise dopamine signalling but does not replace lost neurones or cure the disease.
Check your understanding
Try each question before opening the suggested answer.
Practice question
Retrieval and explanation · suggested answer
Which transmitter falls in Parkinson’s disease, and which brain region loses the cells that release it?
Show suggested answer
Dopamine. The substantia nigra.
Practice question
Retrieval and explanation · suggested answer
How can a reuptake inhibitor increase serotonin signalling?
Show suggested answer
Serotonin stays in the synaptic cleft longer because it is not taken back into the presynaptic neurone, so it can keep binding receptors.
Practice question
Retrieval and explanation · suggested answer
Why is “low serotonin equals depression” too simple for 8.16?
Show suggested answer
The specification says an imbalance can contribute. Other factors are involved, and the NHS description of the illness is about lasting low mood and daily life, not a single chemical test.
Take the idea further
Apply the same specification knowledge to an unfamiliar problem. Any extra assumptions are supplied in the question.
Stretch question
A question says pathway X uses transmitter Y, and the receptors still work, but too little Y is released. Suggest two drug actions that could increase signalling without naming a product. Then say why that suggestion is not a prescription.
Show a hint
More release, slower removal, or a mimic. Then stop.
Explore the reasoning
A drug could increase release or synthesis of Y, mimic Y at the receptor, or block reuptake or breakdown of Y. Any two. It is not a prescription because dose, side effects, other pathways that also use Y, and the person’s diagnosis are unknown. The specification wants the synaptic idea.
Recall this lesson
Lesson recall questions
Question 1 of 5: Name the neurotransmitter whose imbalance is linked with depression in this specification point.
Brain chemicals and illness
Practice question
Retrieval and explanation · suggested answer
Name the neurotransmitter whose imbalance is linked with depression in this specification point.
Lesson: 8B 4: The Chemical Balance of the Brain
Try this from memory first.
Put your biology to work
Explore where these ideas appear in the world. Enrichment, not extra required recall.
Read the NHS sentence before you simplify depression
8B · The Chemical Balance of the BrainThe NHS describes depression as a low mood that can last a long time or keep returning and that affects everyday life. It does not, on that page,…Specification 8.16Read & use the scienceClose article
Why this matters
The NHS describes depression as a low mood that can last a long time or keep returning and that affects everyday life. It does not, on that page, say the cause is low serotonin. The specification separately says a serotonin imbalance can contribute, and that this kind of knowledge is used to develop drugs. Hold both. Do not tell someone that a revision note replaces care. 8.16: dopamine in Parkinson’s disease, serotonin in depression, and drug ideas that change transmission.
Back to the specification
Pearson Edexcel IAL Biology · Issue 2, February 2021 · Unit 5, pp. 35–38. The application extends beyond required recall.
- 8.16 Brain chemicals, ill health and drug development.
Use the science
Why would it be wrong to add “the NHS page says take a serotonin drug” to a 8.16 answer?
Explore a possible response
That page describes the condition. It does not set out a transmitter or a dose. Drug names and whether they are appropriate belong in clinical care, not in this sentence.
Explore the source
A depression headline is not a serotonin assay
8B · The Chemical Balance of the BrainNIMH presents depression as a condition with varied symptoms and causes, and explains that treatment decisions are clinical rather than the result of one simple chemical reading. Specification…Specification 8.16Read & use the scienceClose article
Why this matters
NIMH presents depression as a condition with varied symptoms and causes, and explains that treatment decisions are clinical rather than the result of one simple chemical reading. Specification 8.16 asks how imbalances in brain chemicals can contribute to ill health; “contribute” does not mean that every case has one measured serotonin deficit. Medicines affecting neurotransmission can help some people, but their effect does not prove a single-cause explanation for the condition. This is a useful test of a popular claim: a mechanism proposed for a drug and a complete explanation of a person’s illness are not the same thing.
Back to the specification
Pearson Edexcel IAL Biology · Issue 2, February 2021 · Unit 5, pp. 35–38. The application extends beyond required recall.
- 8.16 Brain chemicals, ill health and drug development.
Use the science
Why does improvement after a medicine that affects serotonin not prove that low serotonin was the sole cause of a person’s depression?
Explore a possible response
A treatment can change one pathway and improve symptoms in a complex condition. Response to treatment does not isolate a single original cause, and other biological and environmental factors can contribute.
Explore the source
- DepressionUS National Institute of Mental Health